123 related articles for article (PubMed ID: 38547743)
21. Distinguishing intrahepatic cholangiocarcinoma from hepatocellular carcinoma in patients with and without risks: the evaluation of the LR-M criteria of contrast-enhanced ultrasound liver imaging reporting and data system version 2017.
Li F; Li Q; Liu Y; Han J; Zheng W; Huang Y; Zheng X; Cao L; Zhou JH
Eur Radiol; 2020 Jan; 30(1):461-470. PubMed ID: 31297632
[TBL] [Abstract][Full Text] [Related]
22. Clinical application of dynamic contrast enhanced ultrasound in monitoring the treatment response of chemoradiotherapy of pancreatic ductal adenocarcinoma.
Zhang Q; Wu L; Yang D; Qiu Y; Yu L; Dong Y; Wang WP
Clin Hemorheol Microcirc; 2020; 75(3):325-334. PubMed ID: 31985457
[TBL] [Abstract][Full Text] [Related]
23. Patterns of appearance and risk of misdiagnosis of intrahepatic cholangiocarcinoma in cirrhosis at contrast enhanced ultrasound.
Galassi M; Iavarone M; Rossi S; Bota S; Vavassori S; Rosa L; Leoni S; Venerandi L; Marinelli S; Sangiovanni A; Veronese L; Fraquelli M; Granito A; Golfieri R; Colombo M; Bolondi L; Piscaglia F
Liver Int; 2013 May; 33(5):771-9. PubMed ID: 23445369
[TBL] [Abstract][Full Text] [Related]
24. Factors Affecting the Enhancement Patterns of Intrahepatic Cholangiocarcinoma (ICC) on Contrast-Enhanced Ultrasound (CEUS) and their Pathological Correlations in Patients with a Single Lesion.
Yuan MX; Li R; Zhang XH; Tang CL; Guo YL; Guo DY; Luo MK
Ultraschall Med; 2016 Dec; 37(6):609-618. PubMed ID: 25919414
[No Abstract] [Full Text] [Related]
25. Feasibility of Using Volumetric Contrast-Enhanced Ultrasound with a 3-D Transducer to Evaluate Therapeutic Response after Targeted Therapy in Rabbit Hepatic VX2 Carcinoma.
Kim J; Kim JH; Yoon SH; Choi WS; Kim YJ; Han JK; Choi BI
Ultrasound Med Biol; 2015 Dec; 41(12):3131-9. PubMed ID: 26365926
[TBL] [Abstract][Full Text] [Related]
26. Modified response evaluation criteria in solid tumors and European Association for The Study of the Liver criteria using delayed-phase imaging at an early time point predict survival in patients with unresectable intrahepatic cholangiocarcinoma following yttrium-90 radioembolization.
Camacho JC; Kokabi N; Xing M; Prajapati HJ; El-Rayes B; Kim HS
J Vasc Interv Radiol; 2014 Feb; 25(2):256-65. PubMed ID: 24461131
[TBL] [Abstract][Full Text] [Related]
27. Comparison of Choi criteria and Response Evaluation Criteria in Solid Tumors (RECIST) for intrahepatic cholangiocarcinoma treated with glass-microspheres Yttrium-90 selective internal radiation therapy (SIRT).
Beuzit L; Edeline J; Brun V; Ronot M; Guillygomarc'h A; Boudjema K; Gandon Y; Garin E; Rolland Y
Eur J Radiol; 2016 Aug; 85(8):1445-52. PubMed ID: 27423686
[TBL] [Abstract][Full Text] [Related]
28. Characteristics of contrast-enhanced ultrasound in distinguishing small (≤3 cm) hepatocellular carcinoma from intrahepatic cholangiocarcinoma.
Shin SK; Choi DJ; Kim JH; Kim YS; Kwon OS
Medicine (Baltimore); 2018 Oct; 97(41):e12781. PubMed ID: 30313099
[TBL] [Abstract][Full Text] [Related]
29. Combined hepatocellular-cholangiocarcinoma: can we use contrast-enhanced ultrasound Liver Imaging Reporting and Data System (LI-RADS) to predict the patient's survival?
Yang J; Huang JY; Chen X; Ling WW; Luo Y; Shi YJ; Liu JB; Lu Q; Lyshchik A
Eur Radiol; 2021 Aug; 31(8):6397-6405. PubMed ID: 33492470
[TBL] [Abstract][Full Text] [Related]
30. The Degree of Contrast Washout on Contrast-Enhanced Ultrasound in Distinguishing Intrahepatic Cholangiocarcinoma from Hepatocellular Carcinoma.
Han J; Liu Y; Han F; Li Q; Yan C; Zheng W; Wang J; Guo Z; Wang J; Li A; Zhou J
Ultrasound Med Biol; 2015 Dec; 41(12):3088-95. PubMed ID: 26386477
[TBL] [Abstract][Full Text] [Related]
31. Regional chemotherapy for unresectable intrahepatic cholangiocarcinoma: a potential role for dynamic magnetic resonance imaging as an imaging biomarker and a survival update from two prospective clinical trials.
Konstantinidis IT; Do RK; Gultekin DH; Gönen M; Schwartz LH; Fong Y; Allen PJ; D'Angelica MI; DeMatteo RP; Klimstra DS; Kemeny NE; Jarnagin WR
Ann Surg Oncol; 2014 Aug; 21(8):2675-83. PubMed ID: 24664624
[TBL] [Abstract][Full Text] [Related]
32. Intrahepatic peripheral cholangiocarcinoma (IPCC): comparison between perfusion ultrasound and CT imaging.
D'Onofrio M; Vecchiato F; Cantisani V; Barbi E; Passamonti M; Ricci P; Malagò R; Faccioli N; Zamboni G; Pozzi Mucelli R
Radiol Med; 2008 Feb; 113(1):76-86. PubMed ID: 18338129
[TBL] [Abstract][Full Text] [Related]
33. Contrast-enhanced ultrasound (CEUS) for differentiating between hepatocellular and cholangiocellular carcinoma.
Bohle W; Clemens PU; Heubach T; Zoller WG
Ultraschall Med; 2012 Dec; 33(7):E191-E195. PubMed ID: 22194045
[TBL] [Abstract][Full Text] [Related]
34. Risk prediction in intrahepatic cholangiocarcinoma: Direct comparison of the MEGNA score and the 8th edition of the UICC/AJCC Cancer staging system.
Hahn F; Müller L; Mähringer-Kunz A; Schotten S; Düber C; Hinrichs JB; Maschke SK; Galle PR; Bartsch F; Lang H; Weinmann A; Kloeckner R
PLoS One; 2020; 15(2):e0228501. PubMed ID: 32012198
[TBL] [Abstract][Full Text] [Related]
35. Dynamic contrast-enhanced ultrasound improves diagnostic performance in endometrial cancer staging.
Green RW; Epstein E
Ultrasound Obstet Gynecol; 2020 Jul; 56(1):96-105. PubMed ID: 31647145
[TBL] [Abstract][Full Text] [Related]
36. Contrast-enhanced MRI could predict response of systemic therapy in advanced intrahepatic cholangiocarcinoma.
Sheng R; Huang X; Jin K; Gao S; Zeng M; Wu D; Shi G
Eur Radiol; 2022 Aug; 32(8):5156-5165. PubMed ID: 35298678
[TBL] [Abstract][Full Text] [Related]
37. The value of contrast-enhanced ultrasound quantitative parameters in the prognosis prediction of hepatocellular carcinoma after thermal ablation: a retrospective cohort study.
Gu DY; Zhang Y; Hu JX; Qin HY; Lu X; He GB; Shang L
J Gastrointest Oncol; 2022 Oct; 13(5):2522-2531. PubMed ID: 36388675
[TBL] [Abstract][Full Text] [Related]
38. A Study on Correlation between Contrast-Enhanced Ultrasound Parameters and Pathological Features of Diabetic Nephropathy.
Wang Y; Zhao P; Li N; Dong Z; Lin L; Liu J; Liang S; Wang Q; Tang J; Luo Y
Ultrasound Med Biol; 2022 Feb; 48(2):228-236. PubMed ID: 34789402
[TBL] [Abstract][Full Text] [Related]
39. Dynamic enhancement pattern of intrahepatic cholangiocarcinoma on contrast-enhanced ultrasound: the correlation with cirrhosis and tumor size.
Lu Q; Xue LY; Wang WP; Huang BJ; Li CX
Abdom Imaging; 2015 Aug; 40(6):1558-66. PubMed ID: 25725793
[TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetic Analysis of Dynamic Contrast-Enhanced Magnetic Resonance Imaging for Distinguishing Hepatocellular Carcinoma From Cholangiocarcinoma in Pre-Liver Transplantation Evaluation.
Lin CC; Cheng YF; Chiang HJ; Lazo M; Chang CD; Tsang LL; Yu CY; Hsu HW; Chen WT; Wang CC; Liang JL; Eng HL; Chen CL; Ou HY
Transplant Proc; 2016 May; 48(4):1041-4. PubMed ID: 27320551
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
